Erbb2
Entity.
- Evidence
- 23 documents · 10 separate publishers
- Standing
- Added automatically from coverage
- Time
- first seen 18 Apr 2026, last seen 22 Oct 2026
- Measured
- 0% of mentions say something specific about it; the rest only name it
- As of
- 23 Oct 2026
Where this comes from
- medRxiv Oncology · 2026-10-13 · Beyond ERBB2 amplification: RNA and proteomic HER2 assessment for pan-tumor treatment stratification (opens the source in a new tab)
- Frontiers Precision Oncology · 2026-09-16 · Case Report: Dramatic response of trastuzumab rezetecan in an NSCLC patient with EGFR sensitive mutation and primary ERBB2 genetic alterations (opens the source in a new tab)